Eli Lilly CEO Criticizes Amodei's AI Medical Claims Ahead of Anthropic IPO
Start here
Eli Lilly Chairman and CEO Dave Ricks has joined experts in criticizing Anthropic CEO Dario Amodei's claims that AI could rapidly cure cancer and mental illness, made in a video tied to Anthropic's IPO launch. Critics, drawing comparisons to Elizabeth Holmes, say the field lacks the data and that clinical trials cannot be sped up on that timeline. Amodei's promises came as Anthropic prepared to go public, giving the dispute a commercial dimension: the claims are being made by the head of a company seeking investors. Ricks, who leads a major pharmaceutical company, is the most prominent industry figure to push back publicly.
Generated from reports · updated 12 h ago
Report timeline
Follow the reports to see the event from different sides.
- Gary Marcus · The Road to AI We Can TrustEli Lilly CEO Pushes Back on Dario Amodei's Medical Claims Ahead of Anthropic IPO
Eli Lilly Chairman and CEO Dave Ricks has joined experts criticizing Anthropic CEO Dario Amodei's medical overpromises, made in a video tied to Anthropic's IPO launch. Amodei claimed AI could rapidly cure cancer and mental illness, drawing comparisons to Elizabeth Holmes; critics say the field lacks the data and cannot expedite clinical trials on that timeline.
Heat for this event
Not enough continuous observations yet to draw a trend.